EquitiesIndia.com

Healthcare · Drug Manufacturers - Specialty & Generic

Divi's Laboratories Ltd.

DIVISLAB

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as lutein and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

Key metrics

Market Cap

₹1.62 lakh cr

P/E Ratio

65.36x

P/B Ratio

10.85x

ROE

14.64%

ROCE

19.49%

Debt / Equity

0x

Net Margin

23.5%

Dividend Yield

49%

EPS

₹82.53

Period

FY2025

Shareholding pattern

As of Latest
Promoter: 52.04%FII: 28.66%Public: 19.30%

Deep-dive pages

Educational content — not investment adviceThis page presents publicly available information about Divi's Laboratories Ltd. for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing here constitutes investment advice, a recommendation to buy or sell any security, or a solicitation to transact. All financial data shown is sourced from public BSE/NSE filings and is at least 90 days old. Past performance is not indicative of future results. Please consult a SEBI-registered adviser before making any investment decision.